Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9694 | 1064 | 27.9 | 60% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2254 | 4236 | EXCITATION FUNCTIONS//INTEGRAL YIELD//RADIATION SYNOVECTOMY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RHENIUM 186 HEDP | Author keyword | 61 | 95% | 2% | 20 |
2 | BONE PAIN PALLIATION | Author keyword | 51 | 83% | 3% | 29 |
3 | STRONTIUM 89 | Author keyword | 42 | 72% | 3% | 33 |
4 | PAIN PALLIATION | Author keyword | 32 | 62% | 3% | 33 |
5 | SM 153 EDTMP | Author keyword | 26 | 80% | 2% | 16 |
6 | RE 186 HEDP | Author keyword | 23 | 86% | 1% | 12 |
7 | STRONTIUM 89 CHLORIDE | Author keyword | 23 | 100% | 1% | 10 |
8 | EDTMP | Author keyword | 21 | 71% | 2% | 17 |
9 | RE 188 HEDP | Author keyword | 17 | 100% | 1% | 8 |
10 | SAMARIUM 153 EDTMP | Author keyword | 15 | 82% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RHENIUM 186 HEDP | 61 | 95% | 2% | 20 | Search RHENIUM+186+HEDP | Search RHENIUM+186+HEDP |
2 | BONE PAIN PALLIATION | 51 | 83% | 3% | 29 | Search BONE+PAIN+PALLIATION | Search BONE+PAIN+PALLIATION |
3 | STRONTIUM 89 | 42 | 72% | 3% | 33 | Search STRONTIUM+89 | Search STRONTIUM+89 |
4 | PAIN PALLIATION | 32 | 62% | 3% | 33 | Search PAIN+PALLIATION | Search PAIN+PALLIATION |
5 | SM 153 EDTMP | 26 | 80% | 2% | 16 | Search SM+153+EDTMP | Search SM+153+EDTMP |
6 | RE 186 HEDP | 23 | 86% | 1% | 12 | Search RE+186+HEDP | Search RE+186+HEDP |
7 | STRONTIUM 89 CHLORIDE | 23 | 100% | 1% | 10 | Search STRONTIUM+89+CHLORIDE | Search STRONTIUM+89+CHLORIDE |
8 | EDTMP | 21 | 71% | 2% | 17 | Search EDTMP | Search EDTMP |
9 | RE 188 HEDP | 17 | 100% | 1% | 8 | Search RE+188+HEDP | Search RE+188+HEDP |
10 | SAMARIUM 153 EDTMP | 15 | 82% | 1% | 9 | Search SAMARIUM+153+EDTMP | Search SAMARIUM+153+EDTMP |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SR 89 THERAPY | 138 | 81% | 8% | 84 |
2 | SAMARIUM 153 EDTMP | 129 | 85% | 6% | 68 |
3 | SM 153 EDTMP | 79 | 88% | 3% | 37 |
4 | PAINFUL OSSEOUS METASTASES | 71 | 77% | 5% | 49 |
5 | PAIN PALLIATION | 68 | 79% | 4% | 44 |
6 | SR 89 | 66 | 50% | 9% | 94 |
7 | RE 186SN HEDP | 65 | 93% | 2% | 25 |
8 | RE 186 HYDROXYETHYLIDENE DIPHOSPHONATE | 57 | 95% | 2% | 19 |
9 | OSSEOUS METASTASES | 49 | 37% | 10% | 107 |
10 | RHENIUM 186 HEDP | 44 | 88% | 2% | 21 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Systemic Metabolic Radiopharmaceutical Therapy in the Treatment of Metastatic Bone Pain | 2010 | 50 | 92 | 72% |
Burden of skeletal-related events in prostate cancer: unmet need in pain improvement | 2015 | 2 | 42 | 38% |
Radionuclide Therapy for Osseous Metastases in Prostate Cancer | 2015 | 1 | 60 | 55% |
A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer | 2012 | 59 | 13 | 31% |
STRONTIUM-89 THERAPY FOR THE PALLIATION OF PAIN DUE TO OSSEOUS METASTASES | 1995 | 114 | 20 | 95% |
Radiometabolic Treatment of Bone-Metastasizing Cancer: From (186)Rhenium to (223)Radium | 2014 | 6 | 62 | 81% |
Radiopharmaceuticals for the palliation of painful bone metastases - a systematic review | 2005 | 53 | 50 | 98% |
Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases | 2012 | 17 | 86 | 64% |
Therapy of metastatic bone pain | 2001 | 84 | 83 | 78% |
Therapeutic radiopharmaceuticals | 1999 | 515 | 262 | 18% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JIANGSU MOL NUCL MED | 2 | 12% | 1.8% | 19 |
2 | ALPERT WARREN MED | 2 | 67% | 0.2% | 2 |
3 | ISOTOPES PROD | 2 | 67% | 0.2% | 2 |
4 | RRDL | 1 | 19% | 0.6% | 6 |
5 | AEC LIFE SCI | 1 | 33% | 0.3% | 3 |
6 | NECSA | 1 | 33% | 0.2% | 2 |
7 | BIOMOL RECOGNIT CHEM | 1 | 23% | 0.3% | 3 |
8 | RADIOPHARMACEUT DEV | 1 | 21% | 0.3% | 3 |
9 | AMERSHAM PHARMACIA BIOTECH | 1 | 50% | 0.1% | 1 |
10 | CENT IRAN COMPLEX YAZD | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000151906 | PALLIATIVE RADIOTHERAPY//FACILITY SURVEY//PAIN FLARE |
2 | 0.0000132491 | W 188 RE 188 GENERATOR//MO 99 TC 99M GENERATOR//MO 99 |
3 | 0.0000103267 | F 18 FLUORIDE//BONE SCINTIGRAPHY//BONE SCAN INDEX |
4 | 0.0000091777 | AT 211//TARGETED ALPHA THERAPY//BI 213 |
5 | 0.0000089032 | BONE TARGETING//OSTEOTROPIC DRUG DELIVERY SYSTEM//FARNESYL PYROPHOSPHATE SYNTHASE |
6 | 0.0000086855 | RADIATION SYNOVECTOMY//RADIOSYNOVIORTHESIS//SR 90 Y 90 GENERATOR |
7 | 0.0000083129 | TC 99M V DMSA//BIOPHYS RADIOPHARMACEUT//TC 99M VDMSA |
8 | 0.0000080110 | ZOLEDRONIC ACID//SKELETAL RELATED EVENTS//BONE METASTASES |
9 | 0.0000080013 | NEUTRON THRESHOLD REACTION//FISSION NEUTRON SPECTRUM//FISSION SPECTRUM |
10 | 0.0000066921 | ABIRATERONE//ENZALUTAMIDE//CASTRATION RESISTANT PROSTATE CANCER |